Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19
Authors
Keywords
-
Journal
RHEUMATOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-02
DOI
10.1007/s00296-020-04663-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics
- (2020) Qing Cao et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults
- (2020) Wei Xia et al. PEDIATRIC PULMONOLOGY
- COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs
- (2020) Edoardo Conticini et al. ANNALS OF THE RHEUMATIC DISEASES
- What is the true incidence of COVID-19 in patients with rheumatic diseases?
- (2020) Ennio Giulio Favalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
- (2020) Sara Monti et al. ANNALS OF THE RHEUMATIC DISEASES
- How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
- (2020) Piercarlo Sarzi-Puttini et al. AUTOIMMUNITY REVIEWS
- COVID-19 infection and rheumatoid arthritis: Faraway, so close!
- (2020) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
- (2020) Mihai G. Netea et al. CELL
- COVID-19 – Considerations for the paediatric rheumatologist
- (2020) Christian M. Hedrich CLINICAL IMMUNOLOGY
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
- (2020) Durga Prasanna Misra et al. CLINICAL RHEUMATOLOGY
- Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
- (2020) Jacques Fantini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
- (2020) Angela Ceribelli et al. JOURNAL OF AUTOIMMUNITY
- The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic
- (2020) Randy Q. Cron et al. JOURNAL OF RHEUMATOLOGY
- Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs
- (2020) Giovanni Filocamo et al. JOURNAL OF RHEUMATOLOGY
- The Rheumatologist’s Role in COVID-19
- (2020) RANDY Q. CRON et al. JOURNAL OF RHEUMATOLOGY
- Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic
- (2020) ROSIE SCUCCIMARRI et al. JOURNAL OF RHEUMATOLOGY
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Coronavirus Infections in Children Including COVID-19
- (2020) Petra Zimmermann et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Insight into COVID‐2019 for pediatricians
- (2020) Yuanzhe Li et al. PEDIATRIC PULMONOLOGY
- Novel coronavirus infection in children outside of Wuhan, China
- (2020) Qinxue Shen et al. PEDIATRIC PULMONOLOGY
- COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country
- (2020) Francesco Licciardi et al. Pediatric Rheumatology
- Epidemiology of COVID-19 Among Children in China
- (2020) Yuanyuan Dong et al. PEDIATRICS
- COVID-19: an unexpected indication for anti-rheumatic therapies?
- (2020) Bruno Lucchino et al. RHEUMATOLOGY
- Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
- (2020) Tsvetoslav Georgiev RHEUMATOLOGY INTERNATIONAL
- Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
- (2020) Stefania Costi et al. PEDIATRIC DRUGS
- Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
- (2020) Fatih Haşlak et al. Balkan Medical Journal
- American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic
- (2020) Ted R. Mikuls et al. Arthritis & Rheumatology
- Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China
- (2020) Fang Zheng et al. Current Medical Science
- The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
- (2020) Carlo Perricone et al. JOURNAL OF AUTOIMMUNITY
- Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
- (2020) Haiyan Qiu et al. LANCET INFECTIOUS DISEASES
- Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic
- (2020) Zaure Mukusheva et al. RHEUMATOLOGY INTERNATIONAL
- Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
- (2020) Fatih Haslak et al. RHEUMATOLOGY INTERNATIONAL
- Implications of COVID-19 in pediatric rheumatology
- (2020) Ezgi Deniz Batu et al. RHEUMATOLOGY INTERNATIONAL
- Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
- (2018) Pierre Roques et al. Viruses-Basel
- The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study
- (2018) Deniz Aygun et al. CLINICAL RHEUMATOLOGY
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now